Curated Information
Javascript is not enabled on this browser. This site will not work properly without Javascript.
PhosphoSitePlus Homepage PhosphoSitePlus® v6.7.5
Powered by Cell Signaling Technology
Home > Curated Information Page > PubMed Id: 26735018
Lee SB, et al. (2016) An ID2-dependent mechanism for VHL inactivation in cancer. Nature 529, 172-7 26735018
This page summarizes selected information from the record referenced above and curated into PhosphoSitePlus®, a comprehensive online resource for the study of protein post-translational modifications (NAR, 2015, 43:D512-20). To learn more about the scope of PhosphoSitePlus®, click here.
Click on the protein name to open the protein page, and on the RSD number to open the site page.
Download

T27-p - ID2 (human)
Modsite: LGISRSKtPVDDPMS SwissProt Entrez-Gene
Orthologous residues
ID2 (human): T27‑p, ID2 (mouse): T27‑p, ID2 (rat): T27‑p
Characterization
Methods used to characterize site in vivo immunoprecipitation, mass spectrometry, mutation of modification site, phospho-antibody, western blotting
Disease tissue studied:  brain cancer, glioblastoma, glioma
Relevant cell lines - cell types - tissues:  'stem, neural', U87MG (glial)
Cellular systems studied:  cell lines
Species studied:  human, mouse
Enzymes shown to modify site in vitro
Type Enzyme
KINASE DYRK1B (human)
Upstream Regulation
Treatments, proteins and their effect on site modification: 
Treatments Referenced Treatments Manipulated Protein Referenced Protein Effect Notes
hypoxia decrease
EGLN2 (human) increase

T27-p - ID2 (mouse)
Modsite: LGISRsKtPVDDPMS SwissProt Entrez-Gene
Orthologous residues
ID2 (human): T27‑p, ID2 (mouse): T27‑p, ID2 (rat): T27‑p
Characterization
Methods used to characterize site in vivo immunoprecipitation, mass spectrometry, mutation of modification site, phospho-antibody, western blotting
Disease tissue studied:  brain cancer, glioblastoma, glioma
Relevant cell lines - cell types - tissues:  'stem, neural', U87MG (glial)
Cellular systems studied:  cell lines
Species studied:  human, mouse
Upstream Regulation
Potential in vivo enzymes for site: 
Type Enzyme Evidence Notes
KINASE DYRK1A (human) phospho-antibody, co-immunoprecipitation, transfection of wild-type enzyme, siRNA inhibition of enzyme
Downstream Regulation
Effect of modification (function):  molecular association, regulation
Effect of modification (process):  cell growth, inhibited
Modification regulates interactions with: 
Interacting molecule Interacting domains Effect Consequences (function) Consequences (process) Detection assays
VHL (mouse) Disrupts pull-down assay